Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole vs anastrozole in adjuvant treatment of node-positive hormone receptor-positive breast cancer
2005-004263-35Phase 3Terminated
- Sponsor
- Novartis
- Start
- Feb 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in breast cancer comparing Letrozole arm with Anastrozole arm (2 arms). Primary endpoint: Disease-free survival at 5 years. Started Feb 2006; status: terminated.
02
Drugs
letrozoleanastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2005-004263-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004263-35.